Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 PatientsCOVID-19 환자의 2 개의 항 바이러스 요법 조합의 결과 비교Comparative Study Published on 2022-01-072022-09-10 Journal: BioMed Research International [Category] 치료제, [키워드] antiviral therapies arrhythmia Arrhythmias Atazanavir Bilirubin both group both groups clinical outcomes Clinical symptoms Combination combination therapies combination therapy Complication COVID-19 COVID-19 patients drug during treatment evaluated form Hospital stay Hydroxychloroquine hyperbilirubinemia Lopinavir Lopinavir/ritonavir no significant difference Other outcome patients patients with moderate Protease inhibitor regimen Ritonavir Side effect significant increase significantly statistically significant therapeutic Treatment treatment regimens two group two groups [DOI] 10.1155/2022/1522426 PMC 바로가기 [Article Type] Comparative Study
Otitis Media Practice During the COVID-19 PandemicCOVID-19 전염병 동안 중이염 실습Review Published on 2022-01-072022-09-11 Journal: Frontiers in Cellular and Infection Microbiology [Category] MERS, SARS, 치료기술, [키워드] 229E Accuracy acute otitis media acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Admission Adult patients advent alcohol antibiotic burden analysis causative pathogen change changed children clinics closure coronavirus coronavirus disease Coronavirus infection Coronavirus-2 country Course CoV COVID-19 COVID-19 pandemic decrease Diagnosis Diseases doubt eruption global pandemic Health Organization HKU1 hospital humans Infectious diseases initial insertion kindergarten kindergartens limit lockdowns management Masks mastoiditis measure Middle ear Mild mucosa myringotomy nasopharyngeal aspirate nasopharyngeal aspirates NL63 OC43 Other otitis otitis media otitis media with effusion pandemic Patient pediatric positive Post-mortem Practice Prevalence reduction in Regulation reported respiratory respiratory tract infection Respiratory tract infections responsible RNA virus RNA viruses Safe SARS-CoV-2 Schools serotype shown social distancing specimen specimens suggested Surgical Procedure temperature tested the disease ventilating tube Viral Viral load viral shedding viruses wearing masks World Health Organization [DOI] 10.3389/fcimb.2021.749911 PMC 바로가기 [Article Type] Review
Fungal Infections Other Than Invasive Aspergillosis in COVID-19 PatientsReview Published on 2022-01-062022-10-30 Journal: Journal of Fungi [Category] COVID-19, [키워드] aspergillosis Aspergillus COVID-19 critically ill patients Diagnosis diagnostic Endemic Epidemiology feature fungal disease Fungal infection fungal infections heterogeneity incidence increasingly Infection invasive knowledge management Mucormycosis non-Aspergillus fungi non-specific Other outcomes Patient populations protocols SARS-CoV-2 similarity Variability [DOI] 10.3390/jof8010058 PMC 바로가기 [Article Type] Review
Medicines and vaccines supply chains challenges in Nigeria: a scoping reviewResearch Published on 2022-01-052022-10-28 Journal: BMC Public Health [Category] Coronavirus, SARS, [키워드] COVID-19 pandemic Critical database distribution effective Evidence Factor health system implementation management Medicine Nigeria Other resources Result Safe searched sustainable development goal target Vaccine Vaccines Web of Science worsened [DOI] 10.1186/s12889-021-12361-9 PMC 바로가기 [Article Type] Research
COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based SurveyOriginal Paper Published on 2022-01-052022-10-31 Journal: JMIR Public Health and Surveillance [Category] COVID-19, SARS, [키워드] acceptance affected age alleviate Attitude Autoimmune disease Autoimmune diseases automatically Cancer Care Community comorbid condition comorbid conditions Comorbidities Comorbidity conditions conducted country COVID-19 COVID-19 vaccination COVID-19 vaccine cross-sectional determine disseminate enrolled excluded expressed Factor Health Hesitancy incidence independent predictor individual Influenza information injection Local lung media median age Multivariable regression analysis objective Odds ratio Other Patients with cancer Perception Population predictor Prevalence random Reactions Regulatory remained respondent response responsible Result Safety SARS-CoV-2 self-reported systemic Side effect survey the United State the vaccine Trial vaccination Vaccine Vaccine development Vaccine hesitancy Vulnerable [DOI] 10.2196/29872 PMC 바로가기 [Article Type] Original Paper
Casirivimab-imdevimab neutralizing SARS-CoV-2: post-infusion clinical events and their risk factorsShort Report Published on 2022-01-032022-10-30 Journal: Journal of Pharmaceutical Health Care and Sciences [Category] COVID-19, [키워드] 95% CI administration adverse effect Asymptomatic body temperature bradycardia Casirivimab Celsius clinical trial clinical trials computation confidence COVID-19 COVID-19 patient criteria Day died Drug efficacy eligible event events exclusion Factor Fever Follow-up ground glass Ground glass opacity had no hypoxia Imdevimab indicated Inpatient interval Intervention Japan Laboratory Leukocytosis limitation median Multivariate analysis neutralize Neutralizing Other outcome Outpatient oxygen supply Patient pulse oximetry Ratio Retrospective study risk risk factor Risk factors SARS-CoV-2 temperature Two patient vaccination vaccinee was used White blood cell with COVID-19 worsening [DOI] 10.1186/s40780-021-00233-8 PMC 바로가기 [Article Type] Short Report
Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies코로나19 팬데믹 및 기타 공중 보건 비상 상황에서 임상 시험에 참여할 수 있는 기회 할당Article Published on 2022-01-012022-09-11 Journal: The Hastings Center report [Category] 임상, [키워드] allocation approach clinical clinical trial clinical trials COVID-19 Emergency Guidance hospital medical need offer opportunity Other pandemic Patient Public public health public health emergency raised recruitment Research Research Ethics scarcity Support therapeutic interventions Trial trial recruitment. [DOI] 10.1002/hast.1297 PMC 바로가기 [Article Type] Article
Effect of selected wastewater characteristics on estimation of SARS-CoV-2 viral load in wastewater폐수 내 SARS-CoV-2 바이러스 부하 추정에 대한 선택된 폐수 특성의 영향Article Published on 2022-01-012022-09-11 Journal: Environmental research [Category] SARS, 치료기술, [키워드] Adaptive neuro-fuzzy inference system model ammonia amplification approach association Chain Reaction characteristic Characteristics chemical oxygen demand Concentration COVID-19 COVID-19 infections dependent on determine droplet droplet digital PCR Effect Epidemiology flow rate highest Increasing Inference investigated observation Other oxygen oxygen demand parameter parameters permanganate physico-chemical properties physico-chemical property plant plants polymerase chain polymerase chain reaction quantification ranged RNA RNA concentrations robust SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 viral load selected Surveillance System the SARS-CoV-2 total solids Treatment Viral RNA was recorded wastewater Wastewater-based epidemiology [DOI] 10.1016/j.envres.2021.111877 PMC 바로가기 [Article Type] Article
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trialClinical Trial Published on 2022-01-012022-10-04 Journal: EBioMedicine [Category] 바이오마커, 임상, 치료법, [키워드] 1-year follow-up results administration adverse event analyzed antibody benefit Biomarkers Cell China clinical trial cohort study consequence COVID-19 COVID-19 patients double-blind Effectiveness enrolled evaluate Follow-up follow-up time foundation group High-resolution CT Human in both group incidence Innovation interval Lung function lung lesion Major median mesenchymal stem cell Mesenchymal stem cells treatment MSC natural Other outcome outcomes Patient phase 2 trial Placebo placebo-controlled trial plasma positive primary endpoint Program proportion Randomized RCT RCT. recorded recruited reduced Registered reported Science severe COVID-19 stem cell Symptom technology the placebo group Treatment treatment for COVID-19 Trial tumor marker two groups UC-MSC umbilical Volume walking distance [DOI] 10.1016/j.ebiom.2021.103789 PMC 바로가기 [Article Type] Clinical Trial
Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong KongResearch Published on 2022-01-012022-10-31 Journal: Emerging Infectious Diseases [Category] COVID-19, SARS, [키워드] 2019 novel coronavirus disease acute respiratory syndrome Adenovirus adjusted age analyzed children coronavirus coronavirus disease COVID-19 determine Effect febrile Hong Kong hospital Hospitalization increase in indicated Infection infection with influenza infections métapneumovirus nonpharmaceutical intervention Nonpharmaceutical interventions NPI NPIs Other pandemic parainfluenza pediatric pediatrics reduced Regression respiratory respiratory infections respiratory syncytial virus respiratory virus respiratory virus hospitalization SARS-CoV-2 School severe acute respiratory syndrome coronavirus 2 Symptom viruses zoonoses [DOI] 10.3201/eid2801.211099 PMC 바로가기 [Article Type] Research